Are Muscle Relaxers Addictive? Side Effects, Types, and Safe Use

Some muscle relaxers are genuinely addictive, while others carry serious dependence and withdrawal risks without the same compulsive-use pattern. Carisoprodol, for example, is metabolized into a sedative compound called meprobamate and has been misused by an estimated 3.69 million people in the United States. This article breaks down which muscle relaxers carry the highest risk, why they become habit-forming, and what safe use actually looks like.

Are Muscle Relaxers Addictive? The Short Answer

Not all muscle relaxers are equally addictive. Carisoprodol and diazepam carry the highest addiction risk. Baclofen and tizanidine are better described as dependence-forming drugs that can cause dangerous withdrawal. Other common muscle relaxers like cyclobenzaprine and methocarbamol have lower addiction evidence but are still risky when used long-term or combined with other sedatives.

Are Muscle Relaxers Addictive? Understanding the Drug Class

“Muscle relaxer” is not a single drug category. It covers several pharmacologically different medications that work through different pathways in the body. Some act as central nervous system depressants. Some target spinal pathways. Some belong to drug families better known for treating anxiety or seizures.

The Cleveland Clinic divides skeletal muscle relaxants into two broad groups: antispasmodics such as carisoprodol, cyclobenzaprine, metaxalone, methocarbamol, chlorzoxazone, and orphenadrine, and antispastic agents such as baclofen and dantrolene. Tizanidine and diazepam may serve both roles depending on the clinical situation.

This distinction matters because addiction risk depends on mechanism, subjective effects, duration of use, and how the drug interacts with the brain’s reward and inhibitory systems. A drug that produces sedation and mild euphoria is far more likely to become habit-forming than one that acts directly on muscle tissue without crossing into the brain’s reward circuitry.

Why Sedation Creates Risk

Most muscle relaxers are sedating. Sedation can be helpful when painful spasms prevent sleep, but it can also create reinforcement. When a drug reliably reduces anxiety, eases pain, or produces calm, people may begin using it for those effects rather than for the original medical reason.

The Cleveland Clinic notes that some people misuse muscle relaxers alone or with other drugs to produce or enhance euphoria and dissociation. That pattern, using a medication for its psychoactive effects rather than its therapeutic purpose, is one of the clearest early signs of addiction risk.

Which Muscle Relaxers Are Addictive: A Risk Breakdown

The table below summarizes the major muscle relaxers and their relative addiction or dependence concern.

Drug	Main category	Addiction risk	Dependence or withdrawal concern
Carisoprodol (Soma)	Antispasmodic	High	High
Diazepam (Valium)	Benzodiazepine	High	High
Baclofen	Antispastic	Low to moderate	High if stopped abruptly
Tizanidine	Antispastic or antispasmodic	Lower	Moderate to high
Cyclobenzaprine	Antispasmodic	Low to moderate	Possible after prolonged use
Methocarbamol	Antispasmodic	Lower	Lower to moderate
Metaxalone	Antispasmodic	Lower	Lower
Chlorzoxazone	Antispasmodic	Lower	Lower
Orphenadrine	Antispasmodic	Lower to moderate	Lower to moderate
Dantrolene	Antispastic	Low	Lower than baclofen

A review in U.S. Pharmacist states that carisoprodol and diazepam are the skeletal muscle relaxants carrying addiction risk, though all muscle relaxants carry some central nervous system depression risk, particularly in older patients.

Carisoprodol: The Highest-Risk Skeletal Muscle Relaxer

Carisoprodol, sold as Soma, stands apart from most other muscle relaxers because of what happens after you take it. The body converts it into meprobamate, a sedative-anxiolytic drug with its own known abuse potential. This metabolite accumulates and drives much of the drug’s addiction and withdrawal risk.

A published case report described carisoprodol withdrawal symptoms after abrupt cessation and concluded that symptoms most likely resulted from accumulation of meprobamate, the active metabolite of carisoprodol in humans. A later pharmacologic review cited carisoprodol’s direct effects at GABA-A receptors, supporting the idea that its risk is rooted in central inhibitory neurotransmission rather than incidental sedation.

How Carisoprodol Reinforces Use

Carisoprodol can reinforce use in three overlapping ways:

• Negative reinforcement: reducing pain, anxiety, insomnia, or withdrawal discomfort
• Positive reinforcement: producing calm, sedation, dissociation, or mild euphoria
• Polysubstance reinforcement: enhancing the effects of opioids, alcohol, or benzodiazepines

Carisoprodol Withdrawal Symptoms

Withdrawal from carisoprodol can be severe. Recovery.com lists insomnia, vomiting, abdominal cramps, headache, tremors, muscle twitching, poor coordination, hallucinations, and psychosis among common symptoms, and notes that withdrawal can last about two weeks or longer depending on dose, duration, and overall health.

Detox.net adds chills, tachycardia, ataxia, delirium, and in less common but serious cases, seizures. These are not mild discomforts. They are medically significant events that often require supervised detoxification.

The case literature makes this concrete. One 43-year-old man consumed up to 30 or more tablets per day and abruptly stopped. Within 48 hours he developed anxiety, tremors, muscle twitching, insomnia, auditory and visual hallucinations, and bizarre behavior, with symptoms peaking on day four. He required antipsychotic medication and a tapering benzodiazepine protocol.

A separate case series emphasized that carisoprodol withdrawal symptoms, including anxiety, tremulousness, insomnia, jitteriness, muscle twitching, and hallucinations, are likely related to meprobamate accumulation after large amounts of carisoprodol are ingested.

Diazepam: A Muscle Relaxer With Benzodiazepine-Level Risk

Diazepam is sometimes listed among muscle relaxers because it has antispastic and antispasmodic effects. Pharmacologically, though, it is a benzodiazepine first. That means its addiction and dependence risks are fully benzodiazepine-level, regardless of why it was prescribed.

The American Society of Addiction Medicine’s benzodiazepine tapering guideline states that patients who have taken benzodiazepines for longer than a month should not abruptly stop them and should taper gradually under clinical supervision. Severe benzodiazepine withdrawal, including seizures or delirium, requires inpatient or residential medically supervised care.

Grouping diazepam with lower-risk skeletal muscle relaxers when discussing addiction is a clinical mistake. Its benzodiazepine pharmacology determines its risk profile, and that risk is high.

Baclofen and Tizanidine: Dependence Without Classic Addiction

Baclofen is a GABA-B receptor agonist used mainly for neurologic spasticity. It does not produce the same euphoric reinforcement as carisoprodol, but abrupt discontinuation can be dangerous. Withdrawal can include hallucinations or seizures, according to Alpas Wellness.

A 2024 systematic review found that baclofen was the most commonly studied skeletal muscle relaxant in long-term chronic pain research, appearing in 25% of included studies. The same review found the strongest evidence for muscle relaxants in trigeminal neuralgia, neck pain, and painful cramps, but not for fibromyalgia, low back pain, or other common syndromes. The review concluded that clinicians should consider stopping the medication if pain-related goals are not met.

Tizanidine, an alpha-2 adrenergic agonist, carries a different but related concern. A University of Maryland summary of a 2025 retrospective cohort study reported that among adults aged 65 to 99, tizanidine carried a 34% greater adjusted hazard of composite injury outcomes compared with cyclobenzaprine, while baclofen carried a 69% greater risk.

The key distinction for both drugs: they are not best described as “addictive” in the compulsive-use sense, but they are physically dependence-forming and can cause serious harm if stopped abruptly.

Why Are Muscle Relaxers Addictive? The Mechanisms

GABAergic Sedation

The strongest addiction risks cluster around drugs that enhance inhibitory GABAergic signaling. Carisoprodol’s meprobamate metabolite and its direct GABA-A effects make it resemble sedative-hypnotics. Diazepam directly modulates GABA-A receptors. These drugs reduce anxiety and produce calming effects, which makes them reinforcing over time.

Withdrawal-Avoidance Reinforcement

Dependence itself can promote compulsive use. When stopping causes insomnia, tremor, vomiting, anxiety, hallucinations, or seizures, people may continue taking the medication not for pleasure but to avoid withdrawal. This is a powerful and often underappreciated driver of continued use.

Polysubstance Synergy

Muscle relaxers are especially dangerous when mixed with opioids, alcohol, or benzodiazepines. The FDA has warned that combining skeletal muscle relaxants with opioids can cause slowed or difficult breathing or death. One prescribing-pattern study found that nearly 70% of patients prescribed muscle relaxants were simultaneously prescribed an opioid.

Long-Term Use: The Evidence Is Weak

A major finding from recent research is that long-term muscle relaxer use has expanded despite limited evidence supporting it. The 2024 JAMA Network Open systematic review examined 44 studies with 2,482 participants and found that recommendations generally limit skeletal muscle relaxant use to a maximum of 2 to 3 weeks because of central nervous system adverse effects and lack of evidence for long-term benefit.

Prescribing data tells a different story. Continued skeletal muscle relaxant prescribing from U.S. physician visits tripled from 8.5 million to 24.7 million between 2005 and 2016, with older adults receiving a disproportionate share despite heightened fall risk.

Long-term exposure increases tolerance, physical dependence, withdrawal risk, cognitive impairment, falls, and the chance that a medication originally prescribed for pain becomes a crutch for sleep or anxiety. Alpas Wellness notes that anyone who has used muscle relaxers for months or longer should not stop without discussing a taper or medically monitored plan with their prescriber.

Safe Use: What the Evidence Supports

Safe use of prescription muscle relaxers comes down to a few clear principles:

• Use the lowest effective dose for the shortest time needed, generally no more than two to three weeks for most antispasmodics
• Avoid combining muscle relaxers with opioids, benzodiazepines, alcohol, or other sedatives
• Do not stop abruptly after prolonged use, especially with carisoprodol, diazepam, or baclofen
• Tell your prescriber about any history of substance use, anxiety, insomnia, or prior dependence
• Ask about nonpharmacologic options like physical therapy, stretching, heat, and sleep hygiene
• If you are older, ask specifically about fall risk and cognitive effects

The U.S. Pharmacist review emphasizes that nonpharmacologic therapy may be a better option in both the short and long term for older adults, and that skeletal muscle relaxants should not be used long-term in this population.

If you are already taking a muscle relaxer and feel you cannot stop, or if you are taking more than prescribed, that is worth discussing honestly with a clinician. Addiction-oriented summaries describe warning signs that include taking more than prescribed, seeking early refills, mixing with alcohol or opioids, and continuing despite health or relationship problems. These patterns are not moral failures. They are clinical signals that the drug has become a problem and that support is needed.

If you or someone you care about is struggling with muscle relaxer dependence or any prescription medication concern, reaching out for professional support is a reasonable and courageous step. Thoroughbred Wellness and Recovery offers medically supervised detox and personalized treatment for prescription drug dependence. You can learn more or start a conversation through their medical detox program.